SCHEMBL10474158

SCHEMBL10474158

O=C1CC2CCC(=O)N2c2cc(O)cc(O)c21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOTUM Q6P988 3/20 0.45
▸ CYP19A1 P11511 5/20 0.37
▸ CYP3A4 P08684 4/20 0.37
▸ CYP1A1 P04798 4/20 0.37
▸ CYP1A2 P05177 4/20 0.37
▸ CYP1B1 Q16678 4/20 0.37
▸ TTR P02766 4/20 0.37
▸ CYP2C19 P33261 3/20 0.37
▸ HSD17B10 Q99714 3/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ CYP2C9 P11712 2/20 0.37
▸ CA12 O43570 2/20 0.37
▸ SLCO2B1 O94956 2/20 0.37
▸ CA4 P22748 2/20 0.37
▸ PSMB5 P28074 2/20 0.37
▸ CA7 P43166 2/20 0.37
▸ ALOX12 P18054 1/20 0.37
▸ ESR1 P03372 1/20 0.37
▸ SHBG P04278 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10472367 0.91 NOTUM (0.37) NOTUMCYP19A1CYP3A4CYP1A1CYP1A2
SCHEMBL10473774 0.75 CYP19A1 (0.36) CYP19A1CYP3A4CYP1A1CYP1A2CYP1B1
SCHEMBL10466442 0.64 — —
SCHEMBL10474519 0.61 CYP19A1 (0.40) CYP19A1CYP3A4CYP1A1CYP1A2CYP1B1
SCHEMBL10474520 0.61 CYP19A1 (0.40) CYP19A1CYP3A4CYP1A1CYP1A2CYP1B1
SCHEMBL10472620 0.61 CYP19A1 (0.40) CYP19A1CYP3A4CYP1A1CYP1A2CYP1B1
Rolziracetam SCHEMBL1159965 0.61 NOTUM (0.47) NOTUMCYP3A4CYP2C19KMT2ACYP2C9
SCHEMBL10473372 0.61 HSP90AA1 (0.34) ESR2
SCHEMBL2025113 0.60 TTR (0.49) CYP19A1CYP3A4CYP1A1CYP1A2CYP1B1
SCHEMBL13176970 0.60 TTR (0.49) CYP19A1CYP3A4CYP1A1CYP1A2CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4920221-A CENTRAL NERVOUS SYSTEM ACTIVE AGENTS PFIZER INC. (US) 1990-04-24 — — US disclosed
EP-0090516-B1 SUBSTITUTED HEXAHYDROPYRROLO(1,2-A)-QUINOLINE, HEXAHYDRO-1H-PYRIDO(1,2-A)-QUINOLINE, HEXAHYDROBENZO(3)INDENE AND OCTAHYDROPHENANTHRENE CNS AGENTS PFIZER INC. (US) 1988-07-06 — — EP disclosed
EP-0090526-B1 SUBSTITUTED DODECAHYDROTRIPHENYLENES, DECAHYDRO-1H-CYCLOPENTA(1)PHENANTHRENES, DECAHYDRO-1H-PYRIDO(1,2-F)PHENANTHRIDINES AND DECAHYDROPYRROLO(1,2-F)PHENANTHRIDINES AS CNS AGENTS PFIZER INC. (US) 1986-11-26 — — EP disclosed
US-4576964-A ANALGESICS, ANTIEMETICS PFIZER INC. (US) 1986-03-18 — — US disclosed
US-4476131-A ANTIEMETICS, ANALGESICS PFIZER INC. (US) 1984-10-09 — — US disclosed
US-4473704-A ANALGESICS, ANTIEMETICS PFIZER INC. (US) 1984-09-25 — — US disclosed
EP-0090516-A1 Substituted hexahydropyrrolo(1,2-a)-quinoline, hexahydro-1H-pyrido(1,2-a)-quinoline, hexahydrobenzo(3)indene and octahydrophenanthrene CNS agents PFIZER INC. (US) 1983-10-05 — — EP disclosed
EP-0090526-A1 Substituted dodecahydrotriphenylenes, decahydro-1H-cyclopenta(1)phenanthrenes, decahydro-1H-pyrido(1,2-f)phenanthridines and decahydropyrrolo(1,2-f)phenanthridines as CNS agents PFIZER INC. (US) 1983-10-05 — — EP disclosed
Send feedback